The research team will not provide any structured smoking cessation counseling or smoking cessation pharmacotherapy during the study period
A meta-analysis covering over 28,000 patients found that while the overall rate of GI adverse events was similar (approximately 5253% of patients in both groups), serious adverse events occurred somewhat more frequently with higher tirzepatide doses (5.37% at 1015 mg) compared to semaglutide (2.8%)
The choice depends on the research setup, not the peptide itself
Peptides can stay potent for up to 6 months, you will want to store them in a refrigerator
It is different from physical hunger, and it is not a clinical test of whether a GLP-1 medication or dose is working
This course is intended for: RDNs, CDCESs and NDTRs GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition awards 3.75 CPEUs in accordance with the Commission on Dietetic Registration CPEU Approval